Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Developing a Simple Algorithm Based on Multiparameter Flow Cytometry for Fast Screening of Acute Promyelocytic Leukemia

Vitória Ceni Ceni, MD, Katia B Pagnano, MDPhD, Gislaine B O Duarte, MD, Marina DB Pellegrini, Bruno Kosa Duarte, MD PhD, Konradin Metze, MD PhD, Irene Lorand-Metze, MD PhD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-137472

Published: 2020

Journal Articles

A Prospective Study Comparing 99m tc-Sestamibi SPECT/CT with 18 f-FDG PET/CT in Multiple Myeloma Staging: A Potential Resource-Constraint Image Alternative for MM Bone Evaluation

Camila Mosci, MD, Fernando Vieira Pericole, MD PhD, Allan de Oliveira Santos, MD, Mariana Cunha Lima, Elba Cristina Camargo Etchebehere, Barbara Juarez Amorim, Gislaine Borba Duarte, MD, Marcia Torresan Delamain, MD, Carmino Antonio Souza, MD PhD, Irene Lorand-Metze, MD PhD, Celso Dario Ramos, MD PhD

Blood (2018) 132 (Supplement 1): 3543.

https://doi.org/10.1182/blood-2018-99-118228

Published: 2018

Journal Articles

DNMT3A Is Highly Expressed in Bone Marrow Cells from Acute Myeloid Leukemia Patients

Renata Scopim Ribeiro, BSc, MSc, João Agostinho Machado-Neto, BSc, Paula De Melo Campos, MD PhD, Christopher A. Eide, Samantha L Savage, Irene Lorand-Metze, MD PhD, Cristina E. Tognon, PhD, Fernando Ferreira Costa, MD PhD, Brian J. Druker, MD, Sara Teresinha Olalla Saad, MD PhD, Fabiola Traina, MD PhD

Blood (2017) 130 (Supplement 1): 3969.

https://doi.org/10.1182/blood.V130.Suppl_1.3969.3969

Published: 2017

Journal Articles

Influence of BCR-ABL Transcript Type on Outcome in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Imatinib 400 Mg

Katia B.B. Pagnano, MD PhD, Eliana Cristina Martins Miranda, PhD, Marcia T Delamain, MD, Gislaine OLIVEIRA Duarte, MD, Erich Vinicius De Paula, MD PhD, Valquiria Povoa, Bruna Rocha Vergilio, Irene Lorand-Metze, MD PhD, Carmino Antônio De Souza, MD PhD

Blood (2016) 128 (22): 1911.

https://doi.org/10.1182/blood.V128.22.1911.1911

Published: 2016

Journal Articles

Assessment of Cardiovascular Events in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Katia B.B. Pagnano, MD PhD, Paola Morelato Assunção, MD, Roberto Zullli, Marcia T Delamain, MD, Gislaine OLIVEIRA Duarte, Irene Lorand-Metze, MD PhD, Carmino A De Souza, Sr., MD PhD

Blood (2015) 126 (23): 4031.

https://doi.org/10.1182/blood.V126.23.4031.4031

Published: 2015

Journal Articles

Stathmin 1 Silencing Amplifies Ruxolitinib-Induced Apoptosis in JAK2 V617F Cells

João Agostinho Machado-Neto, MSc, Paula de Melo Campos, MD, Patricia Favaro, PhD, Mariana Lazarini, PhD, Adriana Silva Santos Duarte, PhD, Irene Lorand-Metze, MD PhD, Sara Teresinha Olalla Saad, MD PhD, Fabiola Traina, MD PhD

Blood (2014) 124 (21): 3229.

https://doi.org/10.1182/blood.V124.21.3229.3229

Published: 2014

Journal Articles

Stathmin 1 Is Involved In The Highly Proliferative Phenotype Of High-Risk Myelodysplastic Syndromes and Acute Leukemia Cells

João Agostinho Machado-Neto, MSc, Paula de Melo Campos, MD, Patricia Favaro, PhD, Mariana Lazarini, PhD, Irene Lorand-Metze, MD, PhD, Fernando Ferreira Costa, MD, PhD, Sara Teresinha Olalla Saad, MD, PhD, Fabiola Traina, MD, PhD

Blood (2013) 122 (21): 861.

https://doi.org/10.1182/blood.V122.21.861.861

Published: 2013

Journal Articles

IRS2 Associates With JAK2 and May Be Involved In Cell Proliferation Pathways In Chronic Myeloproliferative Neoplasms

Paula de Melo Campos, MD, Joao Machado-Neto, MSc, Adriana Silva Santos Duarte, PhD, Rafaela Mendonça, Irene Lorand-Metze, MD, PhD, Fernando F. Costa, M.D., Ph.D., Sara T O Saad, MD, PhD, Fabiola Traina, M.D., Ph.D.

Blood (2013) 122 (21): 1598.

https://doi.org/10.1182/blood.V122.21.1598.1598

Published: 2013

Journal Articles

Evaluation Of Anemia After Long-Term Treatment With Imatinib In Chronic Myeloid Leukemia In Chronic Phase

Muriel Silva Moura, Katia B. Pagnano, MD, PhD, Thais Benevides, Carmino A De Souza, Sr., MD, PhD, Irene Lorand-Metze, MD, PhD, Marcia T Delamain, MD, Gislaine O. Duarte, PhD, Fernando V Pericole, MD, Priscila Percout, Maria Dias, Bruno Duarte, Paula Campos, Paola Assunção, Luciene Oliveira, Pamela Paul, Eliana Fernandes

Blood (2013) 122 (21): 5200.

https://doi.org/10.1182/blood.V122.21.5200.5200

Published: 2013

Journal Articles

Primary Myelofibrosis Brazilian Patient Journey: From Initial Symptoms To Treatment

Monika Conchon, MD, PhD, Renato S Tavares, MD, Katia B. Pagnano, MD, PhD, Tarcila S Datoguia, MD, Israel Bendit, MD, PhD, Marcia Torresan Delamain, MD, Irene Lorand-Metze, MD, PhD, Danielle Leão, MD, Jose Salvador Rodrigues, MD, PhD

Blood (2013) 122 (21): 5255.

https://doi.org/10.1182/blood.V122.21.5255.5255

Published: 2013

Journal Articles

Familial Mastocytosis: Identification Of KIT K509I Mutation and Its In Vitro Sensitivity To Imatinib, Dasatinib and PKC412

Paula De Melo Campos, MD, João Agostinho Machado-Neto, MSc, Adriana Silva Santos Duarte, PhD, Renata Scopim-Ribeiro, BSc, Flavia Fonseca de Carvalho Barra, MD, José Vassallo, MD, PhD, Irene Lorand-Metze, MD, PhD, Ramon V. Tiu, MD, Fernando Ferreira Costa, MD, PhD, Sara T O Saad, MD, PhD, Fabiola Traina, M.D., Ph.D.

Blood (2013) 122 (21): 5267.

https://doi.org/10.1182/blood.V122.21.5267.5267

Published: 2013

Journal Articles

FMNL1 Is Downregulated In Myelodysplastic Syndromes and Is Involved In Megakaryocytic Differentiation

Matheus Rodrigues Lopes, MSc, João Agostinho Machado-Neto, MSc, Fabiola Traina, MD, PhD, João Kleber Novais Pereira, BSc, Irene Lorand-Metze, MD, PhD, Fernando Ferreira Costa, MD, PhD, Sara Teresinha Olalla Saad, MD, PhD, Patricia Favaro, PhD

Blood (2013) 122 (21): 1519.

https://doi.org/10.1182/blood.V122.21.1519.1519

Published: 2013

Journal Articles

Predictive Value Of Early Molecular Responses In Outcomes Of Patients With Chronic Myeloid Leukemia Treated With Imatinib In First-Line Therapy

Katia B. Pagnano, MD, PhD, Bruna Vergilio, Eliana C M Miranda, MEd, Marcia Torresan Delamain, MD, Maria Helena De Almeida, RN, Vagner O Duarte, Gislaine O. Duarte, PhD, Carmino A De Souza, Sr., MD, PhD, Irene Lorand-Metze, MD, PhD

Blood (2013) 122 (21): 4941.

https://doi.org/10.1182/blood.V122.21.4941.4941

Published: 2013

Journal Articles

Evaluation Of Seasonality In The Incidence Of Promyelocytic Leukemia In Brazil

Karine Sampaio Nunes Barroso, Irene Lorand-Metze, MD, PhD, Katia B. Pagnano, MD, PhD, Eduardo M. Rego, M.D., PhD, Raul A Melo, PhD, Rosane Bittencourt, MD, Ricardo Pasquini, MD, PhD, Evandro Fagundes, MD, Rafael Jacomo, MD, PhD, Carlos S Chiattone, MD, PhD, Maria de Lourdes L. F. Chauffaille, MD, PhD, Konradin Metze, M.D., PhD

Blood (2013) 122 (21): 5005.

https://doi.org/10.1182/blood.V122.21.5005.5005

Published: 2013

Journal Articles

Early Molecular Response Is Predictive Of Overall, Progression-Free and Event-Free Survival In Chronic Myeloid Leukemia Using Second-Generation Tyrosine Kinase Inhibitors After Imatinib Treatment

Beatriz F Ribeiro, Bruna Vergilio, Eliana C M Miranda, MEd, Maria Helena Almeida, RN, Marcia Torresan Delamain, MD, Rosana A Silveira, MSc, Carmino A De Souza, Sr., MD, PhD, Dulcinéia Martins Albuquerque, BSc, MSc, PhD, Andrey dos Santos, PhD, Irene Lorand-Metze, MD, PhD, Vagner O Duarte, Gislaine O. Duarte, PhD, Katia B. Pagnano, MD, PhD

Blood (2013) 122 (21): 1326.

https://doi.org/10.1182/blood.V122.21.1326.1326

Published: 2013

Journal Articles

EUTOS Score Is Predictive of Event-Free Survival, but Not for Progression-Free and Overall Survival in Patients with Early Chronic Phase Chronic Myeloid Leukemia Treated with Imatinib: A Single Institution Experience

Katia B. Pagnano, MD, Irene Lorand-Metze, MD, PhD, Eliana C M Miranda, Vagner O Duarte, Marcia T Delamain, MD, Gislaine O Duarte, MD, Carmino Antonio De Souza, MD, PhD

Blood (2012) 120 (21): 1681.

https://doi.org/10.1182/blood.V120.21.1681.1681

Published: 2012

Journal Articles

A High Angiopoietin-2/Angiopoietin-1 Ratio Independently Predicts Septic Shock Development in Patients with Chemotherapy-Associated Febrile Neutropenia and Hematological Malignancies.

Maiara Marx Luz Fiusa, Carolina Costa-Lima, MD, Gleice Regina Souza, Afonso Celso Vigorito, MD, PhD, Francisco J P Aranha, MD, PhD, Irene Lorand-Metze, MD, PhD, Joyce M Annichino-Bizzacchi, MD, PhD, Carmino Antonio De Souza, MD, PhD, Erich V De Paula, MD, PhD

Blood (2012) 120 (21): 2154.

https://doi.org/10.1182/blood.V120.21.2154.2154

Published: 2012

Journal Articles

Early Assessment of Molecular Response in Chronic Myeloid Leukemia Patients On Dasatinib After Imatinib Failure Identify Patients with Poor Cytogenetic and Molecular Responses

Katia B. Pagnano, MD, Beatriz F Ribeiro, Eliana C M Miranda, Marcia T Delamain, MD, Carmino Antonio De Souza, PhD, Gislaine O Duarte, MD, Bruna Vergilio, Dulcinéia Martins Albuquerque, BSc, MSc, PhD, Andrey dos Santos, PhD, Anderson Tavares, Irene Lorand-Metze, MD, PhD

Blood (2012) 120 (21): 3787.

https://doi.org/10.1182/blood.V120.21.3787.3787

Published: 2012

Journal Articles

ANKHD1 Interacts with the Proapoptotic Protein SIVA and Plays a Role in the Proliferation and Stathmin Activation of Acute Leukemia Cells.

Joao Machado-Neto, MSc, Mariana Lazarini, PhD, Patricia Favaro, PhD, Paula de Melo Campos, MD, Renata Scopim-Ribeiro, BSc, Gilberto Carlos Franchi-Junior, BSc, Alexandre Eduardo Nowill, MD, Irene Lorand-Metze, MD, PhD, Fernando Ferreira Costa, MD, PhD, Sara T. Olalla Saad, MD, PhD, Fabiola Traina, MD, PhD

Blood (2012) 120 (21): 2419.

https://doi.org/10.1182/blood.V120.21.2419.2419

Published: 2012

Journal Articles

Reduced TET2 expression in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Renata Scopim-Ribeiro, BSc, Joao Machado-Neto, MSc, Paula de Melo Campos, MD, Patricia Favaro, PhD, Adriana S. S. Duarte, PhD, Valeria Visconte, PhD, Irene Lorand-Metze, MD, PhD, Fernando Ferreira Costa, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD, Ramon V. Tiu, MD, Sara T. Olalla Saad, MD, PhD, Fabiola Traina, MD, PhD

Blood (2012) 120 (21): 2822.

https://doi.org/10.1182/blood.V120.21.2822.2822

Published: 2012

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Developing a Simple Algorithm Based on Multiparameter Flow Cytometry for Fast Screening of Acute Promyelocytic Leukemia

A Prospective Study Comparing 99m tc-Sestamibi SPECT/CT with 18 f-FDG PET/CT in Multiple Myeloma Staging: A Potential Resource-Constraint Image Alternative for MM Bone Evaluation

DNMT3A Is Highly Expressed in Bone Marrow Cells from Acute Myeloid Leukemia Patients

Influence of BCR-ABL Transcript Type on Outcome in Patients with Chronic-Phase Chronic Myeloid Leukemia Treated with Imatinib 400 Mg

Assessment of Cardiovascular Events in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Stathmin 1 Silencing Amplifies Ruxolitinib-Induced Apoptosis in JAK2 V617F Cells

Stathmin 1 Is Involved In The Highly Proliferative Phenotype Of High-Risk Myelodysplastic Syndromes and Acute Leukemia Cells

IRS2 Associates With JAK2 and May Be Involved In Cell Proliferation Pathways In Chronic Myeloproliferative Neoplasms

Evaluation Of Anemia After Long-Term Treatment With Imatinib In Chronic Myeloid Leukemia In Chronic Phase

Primary Myelofibrosis Brazilian Patient Journey: From Initial Symptoms To Treatment

Familial Mastocytosis: Identification Of KIT K509I Mutation and Its In Vitro Sensitivity To Imatinib, Dasatinib and PKC412

FMNL1 Is Downregulated In Myelodysplastic Syndromes and Is Involved In Megakaryocytic Differentiation

Predictive Value Of Early Molecular Responses In Outcomes Of Patients With Chronic Myeloid Leukemia Treated With Imatinib In First-Line Therapy

Evaluation Of Seasonality In The Incidence Of Promyelocytic Leukemia In Brazil

Early Molecular Response Is Predictive Of Overall, Progression-Free and Event-Free Survival In Chronic Myeloid Leukemia Using Second-Generation Tyrosine Kinase Inhibitors After Imatinib Treatment

EUTOS Score Is Predictive of Event-Free Survival, but Not for Progression-Free and Overall Survival in Patients with Early Chronic Phase Chronic Myeloid Leukemia Treated with Imatinib: A Single Institution Experience

A High Angiopoietin-2/Angiopoietin-1 Ratio Independently Predicts Septic Shock Development in Patients with Chemotherapy-Associated Febrile Neutropenia and Hematological Malignancies.

Early Assessment of Molecular Response in Chronic Myeloid Leukemia Patients On Dasatinib After Imatinib Failure Identify Patients with Poor Cytogenetic and Molecular Responses

ANKHD1 Interacts with the Proapoptotic Protein SIVA and Plays a Role in the Proliferation and Stathmin Activation of Acute Leukemia Cells.

Reduced TET2 expression in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only